Full text

Turn on search term navigation

Error in Figure

In the original publication [1], there was a mistake in Figure 5: There was no drastic change in body weight between day 0 and day 1. Day 0 data were entered mistakenly as zero instead of the actual weight prior to administration. The text on the y axis of the graph should have indicated body weight and not % body weight. The corrected Figure 5 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

[Figure omitted. See PDF]

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

1. AlRasheed, H.; Almomen, A.; Aljohar, H.I.; Arafah, M.; Almotawa, R.Y.; Alossaimi, M.A.; Alzoman, N.Z. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals; 2022; 15, 1400. [DOI: https://dx.doi.org/10.3390/ph15111400] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36422530]

Word count: 191

Show less

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Details

Title
Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals 2022, 15, 1400
Author
AlRasheed, Hajer 1 ; Almomen, Aliyah 1   VIAFID ORCID Logo  ; Aljohar, Haya I 1 ; Arafah, Maria 2   VIAFID ORCID Logo  ; Almotawa, Rana Y 1   VIAFID ORCID Logo  ; Alossaimi, Manal A 3 ; Alzoman, Nourah Z 1   VIAFID ORCID Logo 

1  Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia; [email protected] (H.A.); [email protected] (H.I.A.); [email protected] (R.Y.A.); [email protected] (N.Z.A.) 
2  Department of Pathology, College of Medicine, King Saud University, P.O. Box 2925, Riyadh 11421, Saudi Arabia; [email protected] 
3  Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdelaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia; [email protected] 
First page
1
Publication year
2025
Publication date
2025
Publisher
MDPI AG
e-ISSN
14248247
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.3390/ph18010001
ProQuest document ID
3159525236
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.